Zager Richard A, Johnson Ali C M, Hanson Sherry Y
The Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Kidney Int. 2003 Jul;64(1):128-39. doi: 10.1046/j.1523-1755.2003.00059.x.
Experimental and clinical investigations suggest that oxidant stress is a critical determinant of radiocontrast nephropathy (RCN), and that N acetyl cysteine (NAC) can prevent this damage. This study addresses these issues directly at the tubular cell level. Potential alternative mechanisms for RCN have also been sought.
Isolated mouse proximal tubule segments (PTS), or cultured proximal tubule (HK-2) cells, were subjected to radiocontrast media (RCM) (Ioversol, Optiray 320) exposure, followed by assessments of cellular viability [% lactate dehydrogenase (LDH) release, tetrazolium dye (MTT), uptake] and lipid peroxidation. These experiments were conducted in the absence or presence of a variety of antioxidants [NAC, glutathione (GSH), superoxide dismutase, catalase] or pro-oxidant (GSH depletion, heme oxygenase inhibition) strategies. RCM effects on mitochondrial and plasma membrane integrity were also assessed.
RCM exposure did not induce PTS lipid peroxidation. Neither antioxidant nor pro-oxidant interventions mitigated or exacerbated RCM-induced tubular cell injury, respectively. RCM impaired mitochondrial integrity, as assessed by ouabain-resistant ATP reductions, and by cytochrome c release (before cell death). RCM also induced plasma membrane damage, as indicated by loss of key resident proteins (NaK-ATPase, caveolin) and by increased susceptibility to phospholipase A2 (PLA2) attack (increase of >/=2 times in free fatty acid and NaK-ATPase release). Hyperosmolality could not account for RCM's toxic effects.
RCM toxicity can be dissociated from tubular cell oxidant stress. Alternative mechanisms may include mitochondrial injury/cytochrome c release and plasma membrane damage. The latter results in critical protein loss, as well as a marked increase in plasma membrane susceptibility to exogenous/endogenous PLA2 attack.
实验和临床研究表明,氧化应激是放射性造影剂肾病(RCN)的关键决定因素,并且N-乙酰半胱氨酸(NAC)可以预防这种损伤。本研究直接在肾小管细胞水平解决这些问题。还探索了RCN的潜在替代机制。
将分离的小鼠近端肾小管节段(PTS)或培养的近端肾小管(HK-2)细胞暴露于放射性造影剂(RCM)(碘海醇,欧乃派克320),然后评估细胞活力[乳酸脱氢酶(LDH)释放率、四氮唑染料(MTT)摄取率]和脂质过氧化。这些实验在不存在或存在多种抗氧化剂[NAC、谷胱甘肽(GSH)、超氧化物歧化酶、过氧化氢酶]或促氧化剂(GSH耗竭、血红素加氧酶抑制)策略的情况下进行。还评估了RCM对线粒体和质膜完整性的影响。
RCM暴露未诱导PTS脂质过氧化。抗氧化剂和促氧化剂干预均未分别减轻或加重RCM诱导的肾小管细胞损伤。通过哇巴因抗性ATP降低和细胞色素c释放(在细胞死亡前)评估,RCM损害了线粒体完整性。RCM还诱导了质膜损伤,表现为关键驻留蛋白(钠钾ATP酶、小窝蛋白)的丢失以及对磷脂酶A2(PLA2)攻击的敏感性增加(游离脂肪酸和钠钾ATP酶释放增加≥2倍)。高渗性不能解释RCM的毒性作用。
RCM毒性可与肾小管细胞氧化应激分离。替代机制可能包括线粒体损伤/细胞色素c释放和质膜损伤。后者导致关键蛋白丢失,以及质膜对外源/内源性PLA2攻击的敏感性显著增加。